Inhibrx Biosciences (INBX)
Nasdaq • INBX • US45720N1037
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 22, 2026, ORTEX estimated 40% of free float sold short, 16.1 days to cover, cost to borrow 0.46%. Sign up for live short interest data.
Market Cap
1.24b USD | # 4632 in US
Volume
309.7k shares | 30.87m USD
Shares Outstanding
14.72m
Free Float Shares
58.29% | 8.58m
